Maternal plasma transforming growth factor-β1 concentrations in preeclamptic and normotensive pregnant Zimbabwean women

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 17, Issue 5, 2005, Pages 343-348

  Enquobahrie, Daniel A ^a,b,c   Williams, Michelle A ^a,b   Qiu, Chunfang ^a,b   Woelk, Godfrey B ^d   Mahomed, Kassam ^d  

^a SWEDISH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Inflammation; Preeclampsia; Transforming growth factor 1; Tumor necrosis factor soluble receptor p55

Indexed keywords

PROTEIN P55; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; ZIMBABWE;

ADULT; BIOLOGICAL FACTORS; CASE-CONTROL STUDIES; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PRENATAL DIAGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; ZIMBABWE;

EID: 22244464240     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050500132450     Document Type: Article

References (27)

1. Benian A, Madazli R, Aksu F, et al. Plasma and placental levels of interleukin-10, transforming growth factor-β1, and epithelial-cadherin in preeclampsia. Obstet Gynecol 2002;100:327-331.
2. Huber A, Hefler L, Tempfer C, et al. Transforming growth factor-beta 1 serum levels in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2002;81:168-171.
3. Kingsley DM. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994;8:133-146.
4. Bitzer M, Sterzel RB, Bottinger EP. Transforming growth factor-β in renal disease. Kidney Blood Press Res 1998;21:1-12.
5. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
6. Raghupathy R, Tangri S. Immunodystrophism, T cells, cytokines, and pregnancy failure. Am J Reprod Immunol 1996;35:291-296.
7. Floridon C, Nielsen O, Holund B, et al. Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol Hum Reprod 2000;6:943-950.
8. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
9. Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-86.
10. 1) in plasma is associated with preeclampsia risk in Peruvian women with systemic inflammation. Am J Hypertens 2004;17:334-338.
11. Djurovic S, Schjetlein R, Wisloff F, et al. Plasma concentrations of Lp(a) lipoprotein and TGF-B1 are altered in preeclampsia. Clin Genet 1997;52:371-376.
12. Wilczynski Jr, Tchorzewski H, Banasik M, et al. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol 2003;109:8-15.
13. Heikkinen J, Mottonen M, Pulkki K, et al. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 2001;53:310-314.
14. Hennessy A, Orange S, Willis NO, et al. Transforming growth factor-beta 1 does not relate to hypertension in pre-eclampsia. Clin Exp Pharmacol Physiol 2002;29:968-971.
15. Williams MA, Woelk GB, King IB, et al. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens 2003;16:665-672.
16. Williams MA, Mohamed K, Farrand A, et al. Plasma tumor necrosis factor-alpha soluble receptor p55 (sTNFp55) concentrations in eclamptic, preeclamptic and normotensive pregnant Zimbabwean women. J Reprod Immunol 1998;40:159-173.
17. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. ACOG Technical Bulletin 1996;219:1-8.
18. Seelig M. Review and hypothesis: Might patients with the Chronic Fatigue Syndrome have latent tetany of magnesium deficiency. J Chronic Fatigue Syndrome 1998;4(2):77-108.
19. Grainger DJ, Frow EK. Thrombospondin 1 does not activate transforming growth factor B1 in a chemically defined system or in smooth-muscle-cell culture. Biochem J 2000;350:291-298.
20. Clausen T, Djurovic S, Reseland JE, et al. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation? Placenta 2002;23:380-385.
21. Naicker T, Khedun SM, Moodley J. Transforming growth factor beta(1) levels in platelet depleted plasma in African women with pre-eclampsia. J Obstet Gynaecol 2002;22:279-282.
22. Clark DA, Coker R. Transforming growth factor-B. Int J Biochem Cell Biol 1998;30:293-298.
23. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993;90:770-774.
24. Border WA, Ruoslahti E. Transforming growth factor -B in disease: the dark side of tissue repair. J Clin Invest 1993;90:1-7.
25. Grainger DJ, Metcalfe J. A pivotal role for TGF-B in atherogenesis? Biol Rev Camb Phil Soc 1995;70:571-596.
26. Reiss M. Transforming growth factor-beta and cancer: a love-hate relationship? Oncol Res 1997;9:447-457.
27. 1) in autoimmune diseases. J Autoimmun 2000;14:23-42.